A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

Understanding bacterial growth mechanisms can potentially help uncover novel drug targets that are crucial for maintaining cellular viability, particularly for bacterial pathogens. In this important ...

Pennsylvania health officials reviewed the case and determined "no public health action is currently necessary," the ...

Mycobacterium tuberculosis, the causative agent of tuberculosis, produces toxins and their antidotes to regulate its growth ...

You will be redirected to our submission process. Tuberculosis (TB), caused by the Mycobacterium tuberculosis complex (MTBC) bacteria, is a devastating, chronic infectious disease of humankind, ...

Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that ...

Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

During the peer-review process the editor and reviewers write an eLife assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...